D-0541-2018 Class III Terminated

Recalled by Teva Pharmaceuticals USA — North Wales, PA

Recall Details

Product Type
Drugs
Report Date
February 14, 2018
Initiation Date
January 29, 2018
Termination Date
September 5, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
929,916 (5 pouches/carton)

Product Description

Fentanyl Transdermal System, 50 mcg/h, packaged in 5 pouch system cartons (NDC 0591-3212-72), Rx Only, Manufactured by: Actavis Laboratoies UT, Inc. Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054 USA. Individual pouch NDC 0591-3212-54.

Reason for Recall

Failed Impurities/Degradation Specifications: Fentanyl-n-Oxide (FNO) degradant exceeding the specification limits

Distribution Pattern

Distributed nationwide within the United States

Code Information

Lot #: 1103917A, Exp. Feb 2018; 1114192A, Exp. Apr 2018; 1125605A, Exp. Jun 2018; 1138897A, 1153171A, Exp. Aug 2018; 1156261A, Exp. Oct 2018; 1171595A, Exp. Nov 2018; 1179544A, Exp. Jan 2019; 1189531A, Exp. Mar 2019; 1211389A,Exp. May 2019; 1227468A, Exp. Jun 2019; 1231784A, 1232943A, Exp. Sep 2019.